Cerner isn't the only EHR vendor looking to expand its reach as the industry continues to talk about the move to value.
The FDA is evaluating ways to make sure patients don't take an inappropriate over-the-counter drug. That could include adding information to the packaging label and offering online questionnaires to help people decide if a drug is right for them.
Abbott Laboratories needs to decide whether to jump back into the merger arena or rely on internal revenue sources to drive growth and support Abbott's shares, which have leveled off since climbing 40% to a five-year peak of $63.62 during the 12 months ended in March.
While some proton therapy centers across the country have reportedly struggled to stay profitable, officials at University Hospitals in Cleveland say they've found the "sweet spot" two years after the health system opened its own $30 million center.